Shiratsuchi Hideki, Hirakawa Naoya, Saito Tsuyoshi, Oda Yoshinao, Yamamoto Hidetaka, Tomita Kichinobu, Yamamoto Tomoya, Tsuneyoshi Masazumi
Department of Anatomic Pathology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Oncol Rep. 2004 Mar;11(3):597-604.
The conversion from a carcinomatous component to a sarcomatous one in spindle cell carcinoma (SPCC) of the upper aerodigestive tract is thought to occur via a series of molecular alterations; however the detailed mechanism is still unknown. We examined mutations at the H-ras and p53 genes in 16 SPCCs of upper aerodigestive tracts using PCR-RFLP, PCR-SSCP and direct sequencing analysis. The two distinct components, sarcomatous and carcinomatous components in SPCC, were analyzed independently. p53 mutations were detected in both components of SPCC (50.0%, 8/16), and those in the sarcomatous component were completely in accordance with those in the carcinomatous one. In contrast, H-ras mutations were detected only in the sarcomatous component (12.5%, 2/16), and not in the carcinomatous one (0%, 0/16). There was a statistically significant difference in prognosis between the patients with the H-ras mutation (n=2) and those without (n=14); the former had poorer prognosis (P=0.0049). Our results seem to suggest that the H-ras mutation is a relatively uncommon event in SPCC; however, the presence of H-ras mutations may be associated with a more malignant potential in SPCC, while actually occurring during the sarcomatous change itself.
上消化道梭形细胞癌(SPCC)中癌性成分向肉瘤性成分的转变被认为是通过一系列分子改变发生的;然而,详细机制仍不清楚。我们使用聚合酶链反应-限制性片段长度多态性(PCR-RFLP)、聚合酶链反应-单链构象多态性(PCR-SSCP)和直接测序分析,检测了16例上消化道SPCC中H-ras和p53基因的突变。对SPCC中肉瘤性和癌性这两种不同成分进行了独立分析。在SPCC的两种成分中均检测到p53突变(50.0%,8/16),肉瘤性成分中的突变与癌性成分中的完全一致。相比之下,仅在肉瘤性成分中检测到H-ras突变(12.5%,2/16),而在癌性成分中未检测到(0%,0/16)。H-ras突变患者(n = 2)与未发生突变患者(n = 14)的预后存在统计学显著差异;前者预后较差(P = 0.0049)。我们的结果似乎表明,H-ras突变在SPCC中是相对不常见的事件;然而,H-ras突变的存在可能与SPCC中更高的恶性潜能相关,且实际上是在肉瘤样改变过程中发生的。